XWELL Inc(XWEL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 4:00 PM ET (Korea 10/24 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -5.07 | Insider Own | 45% | Shs Outstand | 8.5M | Perf Week | -7.01% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 5.5M | Perf Month | -23.28% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 9% | Short Float | 2.61% | Perf Quarter | -35.61% |
| Income | -0.03B | P/S | 0.24 | EPS this Y | - | Inst Trans | 49.22% | Short Ratio | 3.54 | Perf Half Y | -44.06% |
| Sales | 0.03B | P/B | - | EPS next 5Y | - | ROA | -119.98% | Short Interest | 0.14M | Perf YTD | 48.11% |
| Book/sh | -0.22 | P/C | 0.58 | EPS past 3/5Y | 10.2% 34.16% | ROE | - | 52W High | -68.98% ($2.20) | Perf Year | -29.25% |
| Cash/sh | 1.18 | P/FCF | - | Sales past 3/5Y | -19.47% 28.35% | ROIC | -687.07% | 52W Low | 167.54% ($0.26) | Perf 3Y | -64.64% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -30.33% | Gross Margin | 31.36% | Volatility(W/M) | 15.9% 9.47% | Perf 5Y | -97.58% |
| Dividend TTM | - | EV/Sales | 0.44 | Sales Y/Y TTM | -7.58% | Oper. Margin | -38.13% | ATR (14) | 0.07 | Perf 10Y | -99.98% |
| Dividend Ex-Date | - | Quick Ratio | 2.21 | EPS Q/Q | 52.99% | Profit Margin | -117.83% | RSI (14) | 33.73 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.27 | Sales Q/Q | -7.08% | SMA20 | -13.51% ($0.79) | Beta | 1.02 | Target Price | $7 |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -22.69% ($0.88) | Rel Volume | 0.89 | Prev Close | $0.68 |
| Employees | 175 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -31.65% ($0.99) | Avg Volume(3M) | 0.04M | Price | $0.68 |
| IPO | 2010/7/27 | Option/Short | No/Yes | Trades | 170 | Volume | 36,148 | Change | -0.16% |
💆 A small wellness and healthcare conglomerate that operates spas, waxing services, and public health testing services at airports, rail terminals, and urban locations. Its business is organized around three core pillars: the airport spa brand "XpresSpa," the specialty waxing brand "Naples Wax Center," and the airport/CDC-partnered biosurveillance service "XpresCheck."
Over the past 1 year, on the lower side
69% below its 1-year high.
Traded about as much as usual. That is 89% of its average volume.
XWEL has a sound balance sheet but weak earning power
Of every $100 in sales, $38.13 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $24. Peers typically go for $432.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -97.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 9.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VXF Vanguard Extended Market Index ETF <0.01% It ranks #41 of 44 in the industry
Based on market cap of $7M.
FAQ
What kind of company is XWEL?
XWEL belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of XWEL?
The market cap of XWEL is approximately $7M, ranking 5,544 within its sector.
What is the 52-week high and low for XWEL?
XWEL has recorded a 52-week high of $2.20 and a low of $0.26.
